作者：
Maximilian Georg,Schliesser [1]
;
Rainer,Claus [2]
;
Thomas,Hielscher [3]
;
Christiane,Grimm [4]
;
Dieter,Weichenhan [5]
;
Jonas,Blaes [1]
;
Benedikt,Wiestler [2]
;
Peter,Hau [3]
;
Johannes,Schramm [2]
;
Felix,Sahm [1]
;
Elisa K,Weiß [2]
;
Markus,Weiler [6]
;
Constance,Baer [7]
;
Friederike,Schmidt-Graf [8]
;
Gabriele,Schackert [9]
;
Manfred,Westphal [1]
;
Anne,Hertenstein [2]
;
Patrick,Roth [1]
;
Norbert,Galldiks [2]
;
Christian,Hartmann [10]
;
Torsten,Pietsch [3]
;
Joerg,Felsberg [10]
;
Guido,Reifenberger [11]
;
Michael Christoph,Sabel [12]
;
Frank,Winkler [13]
;
Andreas,von Deimling [1]
;
Christoph,Meisner [2]
;
Peter,Vajkoczy [10]
;
Michael,Platten [14]
;
Michael,Weller [15]
;
Christoph,Plass [8]
;
Wolfgang,Wick [9]
作者单位：
Department of Neurology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
[1]
Clinical Cooperation Unit of Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[2]
Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[3]
Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
[4]
Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[5]
Neurology Clinic, Regensburg University, Regensburg, Germany.
[6]
Neurosurgery Clinic, University of Bonn Medical Center, TU Munich, Munich, Germany.
[7]
Department of Neuropathology, Heidelberg University Hospital and German Cancer Consortium, Clinical Cooperation Units, Germany.
[8]
Clinical Cooperation Unit of Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[9]
Department of General Neurology, University Hospital Tübingen, Germany.
[10]
Neurology Clinic, TU Munich, Munich, Germany.
[11]
Neurosurgery Clinic, Dresden University Medical Center, Germany.
[12]
Neurosurgery Clinic, University Clinic Hamburg, Eppendorf, Germany.
[13]
Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
[14]
Neurology Clinic, Cologne University, Cologne, Germany.
[15]
Department for Neuropathology, Institute of Pathology, Medical University of Hannover, Hannover, Germany.
[16]
Department of Neuropathology, Heinrich-Heine-University, Germany.
[17]
Department of Neurosurgery, Heinrich-Heine-University, Germany.
[18]
Neurosurgery Clinic, Charité, Berlin, Germany.
[19]
DKTK, Partner Site Essen/Düsseldorf, Düsseldorf, Germany.
[20]
Department of Biostatistics, University Hospital Tübingen, Germany.
[21]
Department Hematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Germany.
[22]
Clinical Cooperation Unit of Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[23]
主题词
抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);脑肿瘤(Brain Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);DNA甲基化(DNA Methylation);达卡巴嗪(Dacarbazine);抗药性, 肿瘤(Drug Resistance, Neoplasm);后成说, 遗传(Epigenesis, Genetic);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);疾病遗传易感性(Genetic Predisposition to Disease);神经胶质瘤(Glioma);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);微RNAs(MicroRNAs);NF-κB(NF-kappa B);表型(Phenotype);预后(Prognosis);启动区, 遗传(Promoter Regions, Genetic);比例危险度模型(Proportional Hazards Models);RNA干扰(RNA Interference);辐射耐受性(Radiation Tolerance);时间因素(Time Factors);转录, 遗传(Transcription, Genetic);转染(Transfection)
DOI
10.18632/oncotarget.13452
PMID
27880937
发布时间
2018-12-02
换一批
换一批
